GHB vs GBL: What Is the Difference?
GBL is a prodrug that becomes GHB in your body, but it is stronger by volume and hits faster. Why that makes it easier to overdose on.
May 31, 2026 · Jordan Mercer
Contents
GBL is a prodrug. Swallow it and enzymes in your blood turn it into GHB within minutes, so the drug acting on your brain is the same one either way. What changes is the delivery. GBL is more potent by volume, absorbs faster, and converts at different rates in different people. The measuring habits that are already unforgiving with GHB are worse with GBL.
If you have a clear bottle and you are not certain which one it is, treat it as GBL and start much lower than you think.
At a glance
| GHB | GBL | |
|---|---|---|
| What it is | The active drug, a GABA-B agonist | A prodrug your body converts to GHB |
| Conversion | None needed | Blood lactonases convert it within minutes |
| Onset | About 15 to 30 minutes | Faster, often 5 to 15 minutes |
| Potency by volume | Baseline | Higher: less liquid delivers the same active dose |
| Dose accuracy | Hard, concentration varies by batch | Harder, smaller doses and person-to-person conversion |
| Overdose window | Roughly 2 to 3x between effect and coma | Same window, easier to climb by accident |
What GBL actually is
GBL is an industrial solvent, the kind of thing that turns up in paint strippers, and your body treats it as a delivery vehicle for GHB. Enzymes called lactonases, mainly paraoxonase-1, hydrolyze GBL’s ring structure into GHB directly in the bloodstream. A 2021 pharmacology review in the AAPS Journal describes the conversion as rapid and not requiring the liver at all, which is a large part of why onset is so quick.
After that conversion, the drug in your brain is GHB. Nothing else. GHB is a central nervous system depressant acting mainly as a GABA-B receptor agonist: euphoria and sedation at low doses, unconsciousness and respiratory depression not far above them. Every risk that belongs to GHB belongs to GBL, because GBL becomes GHB.
A third compound circulates in the same scene: 1,4-butanediol. It also converts to GHB, but through a slower two-step liver pathway using alcohol dehydrogenase. That pathway competes with alcohol for the same enzyme, which makes the combination behave unpredictably.
Three things stack against GBL
It is more potent by volume. GBL converts efficiently and absorbs close to completely, so a smaller volume delivers the same active dose. A GBL dose can run somewhere around half to two-thirds the volume of an equivalent GHB dose. Measure GBL with your GHB dropper habits and you have taken considerably more drug than you meant to.
It absorbs faster. GBL is more fat-soluble than GHB, crosses membranes quickly, and typically comes on in 5 to 15 minutes. A 2009 primate pharmacokinetic study in Psychopharmacology found GBL produced faster onset than its sibling prodrug 1,4-butanediol. A shorter runway means less time to notice you took too much, and more temptation to redose before the first dose has peaked.
Conversion varies between people. Lactonase activity is not identical across individuals, so the same dose can produce different blood levels in different bodies. A 2014 pharmacokinetic study of a single low GBL dose documented that variability. You cannot calibrate off your friend’s dose, and a first-timer has no baseline at all.
Under all three sits GHB’s own problem, which GBL does not create but does make easier to hit: a steep dose-response curve with as little as 2 to 3 times separating a recreational dose from a coma-inducing one.
Concentration is the hazard you cannot see
Both come as clear liquids with no reliable way to judge strength by eye. Two bottles labelled the same can differ severalfold. With GBL the problem compounds, because the effective doses are smaller, so the same concentration error becomes a larger relative overshoot.
Volume rules of thumb are worthless here. “One capful” means nothing without a concentration, and less than nothing when you do not know which of the two liquids you are holding. What works is the same for both:
- Measure with an oral syringe. Not a cap, not a swig.
- Start low with every new bottle, and wait out the full onset before considering more.
- Wait 3 to 4 hours between doses, timed from the first dose, not from when the effect faded. Never redose because “it hasn’t hit yet.” Delayed onset plus a second dose is the classic path to an ambulance.
- Never combine with alcohol or any other depressant. This is the mistake that kills people.
Our GHB dosing guide has the full measurement protocol. It applies to GBL with the standing caution that the doses are smaller.
If someone goes under
The active drug is identical, so the emergency is identical. Watch for sudden loss of consciousness, vomiting while unresponsive, slow or absent breathing, blue lips, limpness.
- Call emergency services. Do not wait to see whether they sleep it off.
- Recovery position, on their side, so vomit does not go into the lungs.
- Stay with them and keep watching their breathing.
- No stimulants. Do not try to wake them with anything.
- Tell paramedics it was GHB or GBL, and name any alcohol or other drugs involved.
GBL is not a different drug from GHB in any way that helps you. It is GHB with a faster fuse. Measure precisely, respect the concentration you cannot see, space the doses, and keep alcohol out of the night entirely.
For effects and risks in full, see our GHB harm reduction guide. For why depressant mixing is so lethal, read GHB and alcohol, and check the interaction checker before combining anything.
Sources
- Felmlee MA, et al. γ-Hydroxybutyric acid: pharmacokinetics, pharmacodynamics, and toxicology. AAPS Journal, 2021. PMID 33417072
- Goodwin AK, et al. Behavioral effects and pharmacokinetics of GHB precursors gamma-butyrolactone and 1,4-butanediol. Psychopharmacology (Berl), 2009. PMID 19198808
- Pharmacokinetics of GHB and detection window in serum and urine after single uptake of a low dose of GBL. Drug Testing and Analysis, 2014. PMID 23733593